Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. PHAR has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
PHAR stock price ended at $9.31 on Monday, after rising0%
The Pharming Group NV stock price increased by 0% on the last trading day (19 May 2025), rising from 9.31 to 9.31. Throughout the last trading session, the stock experienced a fluctuation of 0.00% , ranging from a day low of $9.31 to a day high of 9.31. The price has declined in 5 of the last 10 days, resulting in a total change of -0.75% during this period. On the last day, trading volume increase by -3.37K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 198.00 shares were traded, amounting to approximately 1.84K.
PHAR Technical Signals
PHAR(Pharming Group NV Corp) has 5 buy signals and 1 sell signal now. The current trend is downtrend starting from 2025-05-08. The total price change during this trend is -6.99%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of PHAR over the last 5 trading days is 46.87K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
PHAR Moving Average Analysis
Pharming Group NV's overall moving average trend leans more bullish as of Tuesday, May 20, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $10.490496666666665, and $11.132256666666665. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $8.414016666666665, and $7.7722566666666655. A break-down below any of these levels will issue sell signals.
PHAR Short Selling Analysis
The short sale ratio of Pharming Group NV(PHAR) as of 12 May 2025 is 5.96%, dropping from last trading day. With decreasing price from 10.03 to 9.71. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
1
Buy
5
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.752
Bullish
Momentum (10 days)
MOM_10 > 0
0.35
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.278
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
4.272
Bullish
Moving Average
200-day SMA crosses above 250-day SMA
--
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Moving Average
5-day SMA crosses below 10-day SMA
--
Bearish
PHAR Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Pharming Group NV(PHAR), our algorithm predicts PHAR's 1-month price at $9.15, with an -1.76%downwardshift. Using a similarity score up to 96.84%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Pharming Group NV (PHAR.O) stock, as of Sunday, May 18, 2025 , forecasts a -1.76% change over the next month, based on its high correlation with ODFL.O stock patterns. The similarity between their price movements over the analyzed periods is 96.84%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
PHAR
No Data
ODFL
Down: -1.76%Similarity: 96.84%
Name
Similarity
Up/Down
ODFL.O
96.84%
-1.76%
MSA.N
96.76%
+3.13%
OAKU.O
96.65%
+1.79%
EP.A
96.65%
-10.38%
CELH.O
96.63%
-7.00%
GSIT.O
96.51%
+0.95%
MKTW.O
96.49%
+0.39%
JBL.N
96.45%
-6.33%
TGB.A
96.44%
+53.12%
WU.N
96.44%
+2.83%
PHAR Seasonality Analysis
Based on PHAR's historical stock price data across all years, the probability of a positive return in May is40.00%, suggesting it maynotbe an ideal month to invest in PHAR. In contrast,Januaryoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Pharming Group NV (PHAR.O) stock in January has the highest probability of a positive return (75.00%), while February has the lowest probability (20.00%).
Performance Seasonality
The chart shows Pharming Group NV. (PHAR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Pharming Group NV (PHAR.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. PHAR has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Pharming Group NV (PHAR.O) stock in a year?
The radar chart shows that buying Pharming Group NV (PHAR.O) stock in January has the highest probability of a positive return (75.00%), while February has the lowest probability (20.00%).
How has Pharming Group NV. (PHAR)'s stock price performed over the past three years?
PHAR's stock price fell by -0.70% in 2023,decreased by -12.49% in 2024, and went down by 10.99% in 2025.
Bearish technical signals of PHAR include: 5-day SMA crosses below 10-day SMA.
Is PHAR a buy based on overall technical signals summary?
PHAR has 5 buy signals and 1 sell signals now. Overall the technical rating for PHAR is Strong buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of PHAR.
What is the trend of Pharming Group NV (PHAR)'s moving average?
Pharming Group NV's overall moving average trend leans more bullish as of May 20 2025, with 1 negative signals and 3 positive signal.
What is price prediction for PHAR stock next month?
The price prediction chart for Pharming Group NV (PHAR.O) stock, as of May 18 2025, forecasts a -1.76% change over the next month, based on its high correlation with ODFL stock patterns. The similarity between their price movements over the analyzed periods is 96.84%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for PHAR Stock?
The price prediction for PHAR stock in 2025 is **$11.00**, driven by potential positive earnings reports and moderate growth prospects.
What is price prediction 2030 for PHAR Stock?
### **Price Prediction for PHAR Stock in 2030**
Based on the company's strong revenue growth, expanding product portfolio, and positive cash flow from operations, PHAR stock is expected to reach **$15 per share** by 2030. This prediction is supported by the company's 21% revenue growth in 2024, driven by record RUCONEST® sales and strong Joenja® performance. The stock's technical indicators, such as RSI and MACD, suggest continued upward momentum.